RNA Avidity Biosciences Inc
1,200
$29.50
$0.78
(2.72%)
| Watchers | 1,200 |
| 52-Wk Low | $4.83 |
| 52-Wk High | $30.54 |
| Market Cap | $2.82B |
| Volume | 895,645.00 |
| 52-Wk High | $30.54 |
| 52-Wk Low | $4.83 |
Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of DirectorsPR Newswire • 4 days ago
Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors PR Newswire SAN DIEGO, May 15...
Share to Feed
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights PR Newswire SAN DIEGO...
Avidity Biosciences to Participate in Upcoming Investor Conference Avidity Biosciences to Participate in Upcoming Investor Conference PR Newswire SAN DIEGO, May 8, 2024 SAN DIEGO, May 8, 2024...
Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC 1001) for Treatment of Myotonic Dystrophy Type 1 Avidity Biosciences Receives FDA Breakthrough...
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, April...
Related Stocks: RNA...
This indicator may be signaling RNA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
This is a signal that RNA's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This indicator may be signaling that RNA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Avidity Biosciences to Participate in Upcoming Investor Conferences Avidity Biosciences to Participate in Upcoming Investor Conferences PR Newswire SAN DIEGO, March 27, 2024 SAN DIEGO, March 27, 2024...